Sanda, Martin

Open Protocols

Protocol Name Investigatory Role Biomarkers Data Collections
A Methylation Panel for Bladder Cancer Involved 0 0
EDRN Pre-Validation of Metabolic Biomarkers of Prostate Cancer: Follow up EDRN Challenge Involved 0 0
EDRN Pre-Validation of Multiplex Biomarker in Urine Involved 2 0
Prediction Rules Combining PHI with Urinary RNA Testing for Aggressive Prostate Cancer Detection Leading 0 0
Prediction rules for aggressive prostate cancer in AS population Leading 2 0
Upgrading Reference Set Involved 0 0
URS Reference Set-Sanda (2025) Leading 0 0

Closed Protocols

Protocol Name Investigatory Role Biomarkers Data Collections
Biomarker Detection Using NAPPA Tumor Antigen Arrays: EDRN Supplement Involved 28 0
EDRN Resource Network Exchange Involved 0 0
Methylation & Proteomics-Based Detection of Bladder Cancer Involved 0 0
PCA3 Reference Set Application: T2-Erg-Martin Sanda-Emory (2014) Leading 2 0
PCA3 Validation Study and Urinary Reference Set Involved 2 0
Prostate Rapid Pre-Validation Set Leading 6 0
Prostate Reference Set Application: proPSA-Dan Chan-JHU (2008) Involved 2 0
Prostate Upgrading Team Project Involved 0 0
Standard Specimen Reference Set: Prostate Leading 0 0

Publications

Publication NamePubMed IDJournal
[Value of erythrocyte ferritin in heterozygous A2 and F thalassemias]. 3660184 Sangre (Barc)
CD8<sup>+</sup> T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. 36580918
Covariate adjustment in continuous biomarker assessment. 34811731
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. 38635241
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. 38067373
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. 38814624 JAMA
Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance. 39666350 JAMA Oncol
The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature. 39553440 Urol Case Rep

Interests

Prostate Cancer Biomarkers
I conduct research in discovery, development and validation of multi-omic biomarkers to detect prostate cancer and classify aggresiveness

To update protocols, publications, biomarkers, or science data, please contact the Data Management and Coordinating Center.

Photograph of Sanda, Martin
Site
Emory University
Degree(s)
M.D.
Email
martinsanda@emory.edu
Person ID
5469
EDRN Title
EDRN Principal Investigator
Note
To update contact information, please visit the Data Management and Coordinating Center .